Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease

Experimental and Toxicologic Pathology

Volumn 64, Issue 4, 2012, Pages 273-282

  Schultz, Alini ^a   Mendonca, Leonardo S ^a   Aguila, Marcia B ^a   Mandarim de Lacerda, Carlos A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Beta oxidation; Exercise training; Insulin resistance; Nonalcoholic fatty liver disease

Indexed keywords

CYTOKINE; LIVER ENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; BODY MASS; C57BL 6 MOUSE; COMORBIDITY; CONTROLLED STUDY; DYSLIPIDEMIA; FATTY ACID SYNTHESIS; GENE EXPRESSION; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTROPHY; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PANCREAS ISLET; SEDENTARY LIFESTYLE; SWIMMING; TRAINING;

ADIPOCYTES; ANIMALS; BLOOD CHEMICAL ANALYSIS; BODY WEIGHT; DIETARY FATS; DISEASE MODELS, ANIMAL; EATING; EXERCISE THERAPY; FATTY LIVER; HYPERINSULINISM; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LIVER; MALE; MICE; MICE, INBRED C57BL; PHYSICAL CONDITIONING, ANIMAL; SWIMMING; TREATMENT OUTCOME;

MUS;

EID: 84859431733     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.08.019     Document Type: Article

References (46)

1. Achten J., Jeukendrup A.E. Optimizing fat oxidation through exercise and diet. Nutrition 2004, 20:716-727.
2. Aguila M.B., Pinheiro A.R., Parente L.B., Mandarim-de-Lacerda C.A. Dietary effect of different high-fat diet on rat liver stereology. Liver Int 2003, 23:363-370.
3. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
4. Anstee Q.M., Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006, 87:1-16.
5. Aygun C., Kocaman O., Senturk O. Adiponectin: is it a novel treatment modality to alleviate liver injury in non-alcoholic fatty liver disease (NAFLD)?. Med Hypotheses 2008, 70:457-458.
6. Bauche I.B., El Mkadem S.A., Pottier A.M., Senou M., Many M.C., Rezsohazy R., et al. Overexpression of adiponectin targeted to adipose tissue in transgenic mice: impaired adipocyte differentiation. Endocrinology 2007, 148:1539-1549.
7. Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 2002, 5:545-549.
8. Bradley R.L., Jeon J.Y., Liu F.F., Maratos-Flier E. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008, 295:E586-E594.
9. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004, 114:147-152.
10. Chang S.P., Chen Y.H., Chang W.C., Liu I.M., Cheng J.T. Increase of adiponectin receptor gene expression by physical exercise in soleus muscle of obese Zucker rats. Eur J Appl Physiol 2006, 97:189-195.
11. Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis 2009, 13:545-563.
12. Evangelista F.S., Brum P.C., Krieger J.E. Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. Braz J Med Biol Res 2003, 36:1751-1759.
13. Fabbrini E., Sullivan S., Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010, 51:679-689.
14. Fan J.G., Farrell G.C. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009, 50:204-210.
15. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 40:185-194.
16. Fernandes-Santos C., Carneiro R.E., de Souza Mendonca L., Aguila M.B., Mandarim-de-Lacerda C.A. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Nutrition 2009, 25:818-827.
17. Fernandes-Santos C., Evangelista R.C., Mendonca L.S., Aguila M.B., Mandarim-de-Lacerda C.A. Rosiglitazone aggravates nonalcoholic fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 2009, 38:e80-e86.
18. Ferrannini E. Is insulin resistance the cause of the metabolic syndrome?. Ann Med 2006, 38:42-51.
19. Fraulob J.C., Ogg-Diamantino R., Fernandes-Santos C., Aguila M.B., Mandarim-de-Lacerda C.A. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010, 46:212-223.
20. Gallou-Kabani C., Vige A., Gross M.S., Rabes J.P., Boileau C., Larue-Achagiotis C., et al. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 2007, 15:1996-2005.
21. Gauthier M.S., Couturier K., Charbonneau A., Lavoie J.M. Effects of introducing physical training in the course of a 16-week high-fat diet regimen on hepatic steatosis, adipose tissue fat accumulation, and plasma lipid profile. Int J Obes Relat Metab Disord 2004, 28:1064-1071.
22. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diab Metab 2004, 30:13-19.
23. Haramizu S., Nagasawa A., Ota N., Hase T., Tokimitsu I., Murase T. Different contribution of muscle and liver lipid metabolism to endurance capacity and obesity susceptibility of mice. J Appl Physiol 2009, 106:871-879.
24. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
25. Kriketos A.D., Gan S.K., Poynten A.M., Furler S.M., Chisholm D.J., Campbell L.V. Exercise increases adiponectin levels and insulin sensitivity in humans. Diab Care 2004, 27:629-630.
26. Lelliott C., Vidal-Puig A.J. Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int J Obes Relat Metab Disord 2004, 28(Suppl. 4):S22-S28.
27. Lidofsky S.D. Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment. Curr Diab Rep 2008, 8:25-30.
28. Malhi H., Gores G.J. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008, 28:360-369.
29. Mandarim-de-Lacerda C.A. Stereological tools in biomedical research. An Acad Bras Ciencias 2003, 75:469-486.
30. Marques C.M., Motta V.F., Torres T.S., Aguila M.B., Mandarim-de-Lacerda C.A. Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J Med Biol Res 2010, 43:467-475.
31. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
32. Mayerson A.B., Hundal R.S., Dufour S., Lebon V., Befroy D., Cline G.W., et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 2002, 51:797-802.
33. Nascimento F.A., Barbosa-da-Silva S., Fernandes-Santos C., Mandarim-de-Lacerda C.A., Aguila M.B. Adipose tissue, liver and pancreas structural alterations in C57BL/6 mice fed high-fat-high-sucrose diet supplemented with fish oil (n-3 fatty acid rich oil). Exp Toxicol Pathol 2010, 62:17-25.
34. Nieto-Vazquez I., Fernandez-Veledo S., Kramer D.K., Vila-Bedmar R., Garcia-Guerra L., Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 2008, 114:183-194.
35. O'Donovan G., Kearney E.M., Nevill A.M., Woolf-May K., Bird S.R. The effects of 24 weeks of moderate- or high-intensity exercise on insulin resistance. Eur J Appl Physiol 2005, 95:522-528.
36. Palomer X., Perez A., Blanco-Vaca F. Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease. Med Clin (Barc) 2005, 124:388-395.
37. Postic C., Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diab Metab 2008, 34:643-648.
38. Prins J.B. Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab 2002, 16:639-651.
39. Pyper S.R., Viswakarma N., Yu S., Reddy J.K. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal 2010, 8:e002.
40. Rafiq N., Younossi Z.M. Effects of weight loss on nonalcoholic fatty liver disease. Semin Liver Dis 2008, 28:427-433.
41. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
42. Sene-Fiorese M., Duarte F.O., Scarmagnani F.R., Cheik N.C., Manzoni M.S., Nonaka K.O., et al. Efficiency of intermittent exercise on adiposity and fatty liver in rats fed with high-fat diet. Obesity (Silver Spring) 2008, 16:2217-2222.
43. Tzanavari T., Giannogonas P., Karalis K.P. TNF-alpha and obesity. Curr Dir Autoimmun 2010, 11:145-156.
44. Yin F.C., Spurgeon H.A., Rakusan K., Weisfeldt M.L., Lakatta E.G. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol 1982, 243:H941-H947.
45. Younossi Z.M. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2008, 28:2-12.
46. Zeng Q., Isobe K., Fu L., Ohkoshi N., Ohmori H., Takekoshi K., et al. Effects of exercise on adiponectin and adiponectin receptor levels in rats. Life Sci 2007, 80:454-459.